Although several cell lines lacking CFTR function exhibit similar fatty acid composition abnormalities to that in vivo in humans with CF, this approach can not model the interplay between whole-body lipid abnormalities and organ pathology in CF. The gene discussed is CFTR; the disease is cystic fibrosis.